Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers

Published 2015 View Full Article

Authors

Keywords

Journal

BIOCONJUGATE CHEMISTRY

Volume 26, Issue 5, Pages 919-931

Publisher

American Chemical Society (ACS)

Online

2015-04-28

DOI

10.1021/acs.bioconjchem.5b00223

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

BIOCONJUGATE CHEMISTRY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Ask a Question. Answer a Question.